Orthopaedic manifestations of neurofibromatosis in children: An update

Clinical Orthopaedics and Related Research

Volumn 401, Issue , 2002, Pages 107-118

  Vitale, Michael G ^a   Guha, Abhijit ^a   Skaggs, David L ^a  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; CONFERENCE PAPER; CONGENITAL PSEUDARTHROSIS; DYSTROPHY; FRACTURE FIXATION; GENETIC DISORDER; HUMAN; INTRAMEDULLARY NAILING; NEUROFIBROMATOSIS; PRIORITY JOURNAL; SPINAL CORD; SURGICAL TECHNIQUE; TIBIA;

EID: 0036338527     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/00003086-200208000-00013     Document Type: Conference Paper

References (57)

1. Congenital pseudarthrosis of the leg: Late results
2. Use of an intramedullary rod for the treatment of congenital pseudarthrosis of the tibia
3. Congenital forearm pseudarthrosis. Report of six cases and review of the literature
4. Scoliosis surgery in neurofibromatosis
5. The multifaceted challenges of Proteus syndrome
6. Differential regulation of rasGAP and neurofibromatosis gene product activities
7. Pathology and natural history of congenital pseudarthrosis of the tibia
8. Scoliosis in neurofibromatosis: The natural history with and without operation
9. Congenital pseudarthrosis of the tibia: Treatment by transfer of the ipsilateral fibula with vascular pedicle
10. Neurofibromatosis: Conference statement
11. Neurofibromatosis of the cervical spine: A report of eight cases
12. Neurofibromatosis in the pediatric patient
13. Pitfalls of spinal deformities associated with neurofibromatosis in children
14. Osseous manifestations of neurofibromatosis in childhood
15. Neurofibromatosis in children: The role of the orthopaedist
16. Neurofibromatosis with paraplegia: Report of eight cases
17. The protein product of the neurolibromatosis type I gene is expressed at highest abundance in neurons, Schwann cells, and oligodendrocytes
18. Identification and characterization of the neurofibromatosis type I protein product
19. Abnormal regulation of mammalian p21 ras contributes to malignant tumor growth in von Recklinghausen (type I) neurofibromatosis
20. Modulation of spinal deformities in patients with neurofibromatosis type I
21. MRI findings in children with neurofibromatosis type I: A prospective study
22. Pathophysiology of spinal deformities in neurofibromatosis: An analysis of seventy-one patients who had curves associated with dystrophic changes
23. Ras-GTP levels are elevated in human NF 1 peripheral nerve tumors
24. Expression of the neurofibromatosis 1 (NF1) isoforms in developing and adult rat tissues
25. Identification of the neurofibromatosis type I gene product
26. The cervical spine in neurofibromatosis
27. Congenital pseudarthrosis of the tibia: History, etiology, classification, and epidemiologic data
28. Hypophosphatemic osteomalacia complicating von Recklinghausen's neurofibromatosis: Increase in spinal density on treatment
29. Von Recklinghausen neurofibromatosis: A clinical and population study in south-east Wales
30. Atlantoaxial dislocation associated with neurofibromatosis: Report of three cases
31. Social and emotional problems in children with neurofibromatosis type I: Evidence and proposed interventions
32. Pseudarthrosis of the radius associated with neurofibromatosis: Report of a case and review of the literature
33. The fibula in congenital pseudoarthrosis of the tibia: The EPOS multicenter study: European Paediatric Orthopaedic Society (EPOS)
34. Spine update: The management of scoliosis in neurofibromatosis
35. Introduction to the genetics of primary renal tumors in children
36. TP53 mutations are frequent in malignant NF1 tumors
37. Somatic deletion of the neurofibromatosis type I gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis
38. Genomic organization of the neurofibromatosis 1 gene (NF1)
39. Lisch nodules in neurofibromatosis type I
40. Protrusio acetabuli in neurofibromatosis: Mondysplastic and dysplastic forms
41. Neurofibromatosis and malignant childhood cancers: A survey in Italy, 1970- 83
42. Treatment of congenital pseudoarthrosis of the tibia using the Ilizarov technique
43. Surgical correction of dystrophic spinal curves in neurofibromatosis: A review of 56 patients
44. Differences in patterns of activation of MAP kinases induced by oncogenic ras-p 21 and insulin in oocytes
45. Type I neurofibromatosis and the pediatric patient
46. Lumbosacral dural ectasia in type I neurofibromatosis: Report of two cases
47. Long-term follow-up of von Recklinghausen neurofibromatosis: Survival and malignant neoplasms
48. Descriptive analysis of tibial pseudarthrosis in patients with neurofibromatosis 1
49. Growth charts for young children with neurofibromatosis 1 (NF1)
50. Spinal tumours in neurofibromatosis type I: An MRI study of frequency, multiplicity and variety
51. Neurofibromatosis hyperkyphosis: A review of 33 patients with kyphosis of 80 degrees or greater
52. Spine deformity in neurofibromatosis: A review of one hundred and two patients
53. Cost evaluation of the medical management of neurofibromatosis 1: A prospective study on 201 patients
54. The neurofibromatosis type I gene encodes a protein related to GAP
55. Farnesyltransferase inhibitors block the neurofibromatosis type I (NF1) malignant phenotype
56. Cervical spine abnormalities in neurofibromatosis